Effect of a Coronary-Heart-disease-associated Variant of ADAMTS7 on Endothelial Cell Angiogenesis.

Xiangyuan Pu,Kenneth Chan,Wei Yang,Qingzhong Xiao,Li Zhang,Andrew D. Moore,Chuanju Liu,Tom R. Webb,Mark J. Caulfield,Nilesh J. Samani,Jianhua Zhu,Shu Ye
DOI: https://doi.org/10.1016/j.atherosclerosis.2020.01.015
IF: 5.3
2020-01-01
Atherosclerosis
Abstract:BACKGROUND AND AIMS:Recent studies have unveiled an association between ADAMTS7 gene variation and coronary artery disease (CAD) caused by atherosclerosis. We investigated if the ADAMTS7 Serine214-to-Proline substitution arising from a CAD-associated variant affected angiogenesis, since neovascularization plays an important role in atherosclerosis.METHODS AND RESULTS:ADAMTS7 knockdown in vascular endothelial cells (ECs) attenuated their angiogenesis potential, whereas augmented ADAMTS7-Ser214 expression had the opposite effect, leading to increased ECs migratory and tube formation ability. Proteomics analysis showed an increase in thrombospondin-1, a reported angiogenesis inhibitor, in culture media conditioned by ECs with ADAMTS7 knockdown and a decrease of thrombospondin-1 in media conditioned by ECs with ADAMTS7-Ser214 overexpression. Cleavage assay indicated that ADAMTS7 possessed thrombospondin-1 degrading activity, which was reduced by the Ser214-to-Pro substitution. The pro-angiogenic effect of ADAMTS7-Ser214 diminished in the presence of a thrombospondin-1 blocking antibody.CONCLUSIONS:The ADAMTS7 Ser217-to-Pro substitution as a result of ADAMTS7 polymorphism affects thrombospondin-1 degradation, thereby promoting atherogenesis through increased EC migration and tube formation.
What problem does this paper attempt to address?